HMR
Desconocido
PRISAR2: proactive monitoring of cancer as an alternative to surgery
HAMMERSMITH MEDICINES RESEARCH LTD
participó en un
H2020:
H2020-MSCA-RISE-2019
From 2016 -2019, the first PRISAR consortium implemented the first Dutch RISE project of H2020 to investigate the use of imaging technologie...
2019-12-02 - 2025-03-31 | Financiado
2019-12-02 - 2025-03-31 | Financiado
platinDx: A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for b...
HAMMERSMITH MEDICINES RESEARCH LTD
participó en un
H2020:
H2020-SMEInst-2014-2015
Platinum-based chemotherapy is the primary therapeutic intervention for over 500,000 patients per year in the EU. Although some patients ar...
2015-06-10 - 2015-10-31 | Financiado
2015-06-10 - 2015-10-31 | Financiado
* No se disponen de datos de la empresa actual.